Corvus Pharmaceuticals Provides Update on Clinical Trial of CPI-006 for Patients with COVID-19
Characterization of novel immunotherapy approach with CPI-006 and details of COVID-19 clinical trial results submitted for publication online at medRxiv.orgPatients […]